Stabilization of a hydrophobic recombinant cytokine by human serum albumin
Corresponding Author
Andrea Hawe
Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Germany
Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Germany. Telephone: +49-89-218077019; Fax: +49-89-218077020.Search for more papers by this authorWolfgang Friess
Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Germany
Search for more papers by this authorCorresponding Author
Andrea Hawe
Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Germany
Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Germany. Telephone: +49-89-218077019; Fax: +49-89-218077020.Search for more papers by this authorWolfgang Friess
Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Germany
Search for more papers by this authorAbstract
The objective was to evaluate the impact of pH and NaCl content on aggregation, particle formation, and solubility of a hydrophobic recombinant human cytokine in formulations with human serum albumin (HSA) as stabilizing excipient. While cytokine-HSA formulations were stable at physiological pH, a tremendous increase in turbidity at pH 5.0, close to the isoelectric point of HSA was caused by a partially irreversible precipitation. By dynamic light scattering (DLS), disc centrifugation, atomic force microscopy (AFM), and light obscuration it could be shown that the turbidity was mainly caused by particles larger than 120 nm. SDS–PAGE provided evidence that the precipitation at pH 5.0 was mainly caused by the cytokine. The HSA-stabilizers Na-octanoate and Na-N-acetyltryptophante were less effective in preventing the turbidity increase of unstabilized-HSA compared to NaCl. The interactions between HSA and cytokine were weakened by NaCl, as determined by fluorescence spectroscopy. The positive effect of NaCl on the formulation could be attributed to a direct stabilization of HSA and weaker interactions between HSA and the cytokine, which in consequence provided an overall stabilization of the cytokine. © 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 96: 2987–2999, 2007
REFERENCES
- 1 Lin LS, Kunitani MG, Hora MS. 1996. Interferon-β-1b (Betaseron®); a model for hydrophobic therapeutic proteins. Pharm Biotechnol 9: 275–301.
- 2 Costantino HR. 2004. Excipients for use in lyophilized pharmaceutical peptide, protein, and other bioproducts. In: HR Costantino, MJ Pikal, editors. Lyophilization of biopharmaceuticals. Arlington: AAPS Press. pp 139–228.
- 3 Wang W. 2000. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 203: 1–60.
- 4 Wang PL, Udeani GO, Johnston TP. 1995 Inhibition of granulocyte colony stimulating factor (G-CSF) adsorption to polyvinyl chloride using a nonionic surfactant. Int J Pharm 114: 177–184.
- 5 U.S. Food and Drug Administration. 2004. Code of Federal Regulations. Title 21, Volume 7: 640.80 Albumin (Human), 2006.
- 6 Scatchard G, Strong LE, Hughes WL Jr, Ashworth JN, Sparrow AH. 1945. Chemical, clinical, and immunological studies and the products of human plasma fractionation. XXVI. The properties of human serum albumin at low salt content. J Clin Invest 24: 671–679.
- 7 Ballou GA, Boyer PD, Luck JM, Lum GF. 1944. The heat coagulation of human albumin. J Biol Chem 153: 589–605.
- 8 Saso L, Valentini G, Grippa E, Leone MG, Silvestrini B. 1998. Effect of selected substances on heat-induced aggregation of albumin, IgG and lysozyme. Res Com Mol Pathol Pharmacol 102: 15–28.
- 9 Hawe A, Frieß W. 2006. Physico-chemical, Behavior of mannitol, human serum albumin formulations during lyophilization. Eur J Pharm Sci 28: 224–232.
- 10 Capelle MAH, Gurny R, Avinte T. 2006. High Throughput Screening of Protein–Protein Interactions. Proceedings of the 5th World Meeting on Pharm. Biopharm Pharm Tech Geneva.
- 11 Hershenson S, Thomson J. 1989. Isoelectric focusing of recombinant interferon-β. Appl Theor Electrophr 1: 123–124.
- 12 Huang SL, Lin FY, Yang PC. 2005. Microcalorimetric studies of the effects on the interactions of human recombinant interferon-α2a. Eur J Pharm Sci 24: 545–552.
- 13 Kwan HK. 1985. Biologically stable alpha-interferon formulations. United States Patent No 4,496,537.
- 14 Page C, Dawson P, Woollacott D, Thorpe R, Mire-Sluis A. 2000. Development of o lyophilization formulation that preserves the biological activity of the platelet-inducing cytokine interleukin-11 at low concentrations. J Pharm Pharmacol 52: 19–26.
- 15 Mahler HC, Müller R, Frieß W, Delille A, Matheus S. 2005. Induction and analysis of aggregates in a liquid IgG1-antibody formulation. Eur J Pharm Biopham 59: 407–417.
- 16 Yamasaki M, Yano H, Aoki K. 1990. Differential scanning calorimetric studies on bovine serum albumin: I. Effects of pH and ionic strength. Int J Biol Macromol 12: 263–268.
- 17 Yamasaki M, Yano H. 1990. Differential scanning calorimetric studies on bovine serum albumin: I. Effects of pH and ionic strength. Int J Bio Macromol 12: 263–268.
- 18 Yamasaki M, Yano H. 1991. Differential scanning calorimetric studies on bovine serum albumin: II. Effects of neutral salts and urea. Int J Bio Macromol 13: 322–328.
- 19 Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm Res 20: 1325–1336.
- 20 Anraku M, Tsurusaki Y, Watanabe H, Maruyama T, Kragh-Hansen U, Otagiri M. 2004. Stabilizing mechanisms in commercial albumin preparations: Octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress. Biochim Biophys Acta 1702: 9–17.
- 21 Kragh-Hansen U, Chuang VTG, Otagiri M. 2002. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 25: 695–704.
- 22 Turgeon SL, Beaulieu M, Schmitt C, Sanchez C. 2003. Protein-polysaccharide interaction: Phase ordering kinetics, thermodynamic and structural aspects. Curr Opin Colloid Interface Sci 8: 401–414.
- 23 van der Weert M, Andersen MB, Frokjaer S. 2004. Complex coacervation of lysozyme and heparin: Complex characterization and protein stability. Pharm Res 21: 2354–2359.
- 24 Housk M, Brynda E. 1997. Interactions of proteins with polyelectrolytes at solid/liquid interfaces: Sequential adsorption of albumin and heparin. J Colloid Interf Sci 188: 243–250.
- 25 Rezwan K, Meier LP, Gauckler LJ. 2005. A prediction method for the isoelectric point of binary protein mixtures of bovine serum albumin and lysozyme adsorbed on colloidal titania and alumina particles. Langmuir 21: 3493–3497.
- 26 Koga Y, Westh P, Davies JV, Miki K, Nishikawa K, Katayanagi H. 2004. Toward understanding the Hofmeister series. 1. Effect of sodium salts of some anions on the molecular organization of H2O. J Phys Chem 108: 8533–8541.
- 27 Arakawa T, Timasheff SN. 1982. Preferential interactions of proteins with salts in concentrated solutions. Biochemistry 21: 6545–6552.
- 28 Arakawa T, Timasheff SN. 1984. Mechanism of protein salting in and salting out by divalent cation salts: Balance between hydration and salt binding. Biochemistry 23: 5912–5923.
- 29 Sontum PC, Christiansen C. 1997. Photon correlation spectroscopy applied to characterization of denaturation and thermal stability of human albumin. J Pharm Biomed Anal 16: 295–302.
- 30 Velazquez-Campoy A, Leavitt SA, Freire E. 2004. Characterization of protein–protein interactions by isothermal titration calorimetry. Methods in Molec Biol 261: 35–54.
- 31
Quin L,
Vinogradova O,
Gronenborn AM.
2001.
Protein–protein interactions probed by nuclear magnetic resonance spectroscopy.
Methods Enzymolog
339:
377–389.
10.1016/S0076-6879(01)39323-0 Google Scholar
- 32 Beeckmans S. 1999. Chromatographic methods to study protein–protein interactions. Methods 19: 278–305.
- 33 Ladokhin AS. 2000. Fluorescence spectroscopy in peptide and protein analysis. In: RA Meyers, editor. Encyclopedia of analytical chemistry. Wiley VCH: Weinheim, Germany. pp 5762–5779.
- 34 Jiskoot W, Visser AJWG, Herron JN, Sutter M. 2005. Fluorescence spectroscopy. In: W Jiskoot, DJA Crommelin, editors. Methods for structural analysis of protein pharmaceuticals. Arlington, VA: AAPS Press. pp 27–82.
- 35 Sharma VK, Kalonia DS. 2003. Temperature- and pH-induced multiple partially unfolded states of recombinant human interferon-α 2a: Possible implications in protein stability. Pharm Res 20: 1721–1729.
- 36 Holzman TH, Dougherty JJ, Jr, Brems DN, MacKenzie NE. 1990. pH-induced conformational states of bovine growth hormone. Biochemistry 29: 1255–1261